环球中医药
環毬中醫藥
배구중의약
GLOBAL TCM
2015年
1期
36-41
,共6页
韩琳%秦建国%高誉珊%王媛媛%张晓宇%郭一%宋林梅%罗燕妮%迟笑怡
韓琳%秦建國%高譽珊%王媛媛%張曉宇%郭一%宋林梅%囉燕妮%遲笑怡
한림%진건국%고예산%왕원원%장효우%곽일%송림매%라연니%지소이
降压通络方%自发性高血压大鼠%高血压病肾损害%血管紧张素II
降壓通絡方%自髮性高血壓大鼠%高血壓病腎損害%血管緊張素II
강압통락방%자발성고혈압대서%고혈압병신손해%혈관긴장소II
Jiangya Tongluo Formula%Spontaneously hypertension rat%Hypertension nephro-sclerosis%Angiotensin II
目的:观察降压通络方对自发性高血压肾损害大鼠肾脏血管紧张素II ( angiotensin II, AngII)及肾功能的影响,探讨该方对高血压肾损害大鼠肾脏的保护机制。方法采用16周龄自发性高血压大鼠(Spontaneously Hypertension Rat , SHR)为研究对象,将其随机分为模型组、缬沙坦组、降压通络方高、中、低剂量组、并设正常血压大鼠( Wistar Kyoto, WKY)为空白对照,分别灌胃给药。于给药后4周和8周分别测定大鼠尾动脉压力、血肌酐、尿素氮及肾脏AngII蛋白含量,并进行大鼠肾脏病理组织学检查。结果给药4、8周后,与模型组比较,各治疗组大鼠血压、肾脏AngII含量明显降低(P<0.01,P<0.05),但给药4周各组之间比较无统计学意义,给药8周缬沙坦及降压通络方高、中剂量组均明显低于低剂量组( P<0.05);缬沙坦及降压通络方能显著降低模型组大鼠血肌酐、尿素氮( P<0.01,P<0.05),改善肾小动脉及肾小球硬化,促进肾组织结构的恢复。结论降压通络方能降低高血压肾损伤大鼠肾脏AngII含量,从而有效降低大鼠血压,改善肾脏病理损害,保护肾功能。
目的:觀察降壓通絡方對自髮性高血壓腎損害大鼠腎髒血管緊張素II ( angiotensin II, AngII)及腎功能的影響,探討該方對高血壓腎損害大鼠腎髒的保護機製。方法採用16週齡自髮性高血壓大鼠(Spontaneously Hypertension Rat , SHR)為研究對象,將其隨機分為模型組、纈沙坦組、降壓通絡方高、中、低劑量組、併設正常血壓大鼠( Wistar Kyoto, WKY)為空白對照,分彆灌胃給藥。于給藥後4週和8週分彆測定大鼠尾動脈壓力、血肌酐、尿素氮及腎髒AngII蛋白含量,併進行大鼠腎髒病理組織學檢查。結果給藥4、8週後,與模型組比較,各治療組大鼠血壓、腎髒AngII含量明顯降低(P<0.01,P<0.05),但給藥4週各組之間比較無統計學意義,給藥8週纈沙坦及降壓通絡方高、中劑量組均明顯低于低劑量組( P<0.05);纈沙坦及降壓通絡方能顯著降低模型組大鼠血肌酐、尿素氮( P<0.01,P<0.05),改善腎小動脈及腎小毬硬化,促進腎組織結構的恢複。結論降壓通絡方能降低高血壓腎損傷大鼠腎髒AngII含量,從而有效降低大鼠血壓,改善腎髒病理損害,保護腎功能。
목적:관찰강압통락방대자발성고혈압신손해대서신장혈관긴장소II ( angiotensin II, AngII)급신공능적영향,탐토해방대고혈압신손해대서신장적보호궤제。방법채용16주령자발성고혈압대서(Spontaneously Hypertension Rat , SHR)위연구대상,장기수궤분위모형조、힐사탄조、강압통락방고、중、저제량조、병설정상혈압대서( Wistar Kyoto, WKY)위공백대조,분별관위급약。우급약후4주화8주분별측정대서미동맥압력、혈기항、뇨소담급신장AngII단백함량,병진행대서신장병리조직학검사。결과급약4、8주후,여모형조비교,각치료조대서혈압、신장AngII함량명현강저(P<0.01,P<0.05),단급약4주각조지간비교무통계학의의,급약8주힐사탄급강압통락방고、중제량조균명현저우저제량조( P<0.05);힐사탄급강압통락방능현저강저모형조대서혈기항、뇨소담( P<0.01,P<0.05),개선신소동맥급신소구경화,촉진신조직결구적회복。결론강압통락방능강저고혈압신손상대서신장AngII함량,종이유효강저대서혈압,개선신장병리손해,보호신공능。
Objective o observe the effects of Jiangya Tongluo Formula on the content of AngII in kidney and the renal function in the model of hypertension nephrosclerosis .Methods Sixteen-week-old Spontaneously Hypertension rats were used as research subjects and then the rats were randomly divided in -to 5 groups:a model group , a Valsartan group , 3 Jiangya Tongluo groups and Wistar Kyoto rats were used as control group.All the rats were gavaged respectively .After 4 weeks and 8 weeks, the tail arterial pres-sure of the rats, Serum creatinine , Urea nitrogen and the dose of AngII in kidney were detected , At the same time, the histopathologic change in kidney tissue was also detected .Results After 4 weeks and 8 weeks gavage , compared to model group .The tail arterial pressure and the level of Ang II in kidney was decreased in Jiangya Tongluo groups and Valsartan group (P<0.01,P<0.05).But after 4 weeks gavage, there was no significant difference in therapeutic groups .After 8 weeks gavage , the date in Valsartan and Jiangya Tongluo high and medium dose groups were lower significantly than that of low dose group ( P<0.05).Valsartan and Jiangyatongluo degraded the concentration of SCr , BUN in blood-serum significantly (P<0.01,P<0.05), improved the renal arteries and glomerular sclerosis , promoted the recovery of kid-ney tissue .Conclusion Jiangya Tongluo Formula could reduce the level of Ang II in kidney ,decrease blood pressure , ameliorate renal pathologicallesion and protect renal function .